Dimerix Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported net loss was AUD 6.67 million compared to AUD 9.61 million a year ago. Basic loss per share from continuing operations was AUD 0.01645 compared to AUD 0.02995 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.575 AUD | +6.48% | +16.16% | +180.49% |
May. 29 | Euroz Hartleys Adjusts Dimerix’s Price Target to AU$0.86 From AU$0.80, Keeps at Speculative Buy | MT |
May. 27 | Dimerix Signs License Deal for Kidney Disease Medication in the Middle East | MT |
1st Jan change | Capi. | |
---|---|---|
+180.49% | 198M | |
+55.55% | 59.28B | |
+43.17% | 40.94B | |
-4.71% | 40.17B | |
-5.56% | 28.69B | |
+13.76% | 26.63B | |
-22.00% | 18.89B | |
+31.50% | 12.46B | |
+2.16% | 12.42B | |
+25.70% | 12.26B |
- Stock Market
- Equities
- DXB Stock
- News Dimerix Limited
- Dimerix Limited Reports Earnings Results for the Half Year Ended December 31, 2023